Introduction
Within urban-and economic geography today, cities and regions are becoming central to the understanding of economic growth (Asheim & Gertler 2005 , Florida 2003 , Camagni 2002 . At the same time knowledge-creation, innovation and high-tech industries are pointed out by experts and politicians, as sources of continued economic growth within regions. The Öresund Region is a bi-national region, with the greater Copenhagen area on the Danish side, and the Malmö/Lund area on the Swedish side making up its centre in terms of population, economy and culture. Seen in terms of gross regional product, Copenhagen ranks 19 th of the European cities, but combined with Malmö/Lund it moves up to an 11 th place. Measured in terms of scientific output Copenhagen ranks 21 st in Europe, and Malmö/Lund is situated just inside the top 30, but combined the two urban areas rank 5 th (Matthiessen 1999 and Schwarz 1999) . Therefore it seems obvious that a functional integrated Öresund Region will be better equipped to handle the challenges posed by the increasing global competition between cities and regions. During the last few decades changing Danish and Swedish national and regional governments have sought to bind the two parts of the Öresund Region closer together, in order to promote regional economic growth and increase competitiveness. In 2000 the opening of the fixed link across Öresund resulted in a significant increase in the number of vehicles and people crossing the Öresund, indicating a speed-up of the integration process. The integration process also spawned several bi-national institutions (both public and private) working to create one functional integrated region both in terms of finance, labour market, education, research and culture. Matthiessen (2004) 
examines functional integration in the Öresund
Region both before and after the construction of the fixed link. Based upon data of the crossÖresund traffic of people and vehicles as well as migration and commuting, he finds that the fixed link has had a modest positive effect on the integration of the two parts of the region. At the same time he identifies a number of barriers slowing down the integration process e.g. high toll on the bridge and differences in labour market and social laws. Bucken-Knapp (2001) pays attention to the importance of involving the everyday residents of the region in the creation of an integrated Öre-sund Region. According to Bucken-Knapp it is essential that it is not only the cultural and political elites who commit themselves to the Öresund project. For a full discussion on the border regional problem see Matthiessen (2004) and Knowles (2006) .
Figure 1. Map of the Öresund Region
The present paper examines how the integration of the two parts of the Öresund Region is proceeding, but concentrates on the world of science and in particular the biotech industry. Biotech is selected as our area of interest because it is one of the centres of attention in the Öresund Region, when it comes to securing continued economic growth. The analysis identifies the volume of coauthorships between researchers from the Danish and Swedish parts of the Region, and it is carried out for each year in the period [1994] [1995] [1996] [1997] [1998] [1999] [2000] [2001] [2002] [2003] [2004] [2005] . During the analysis three four-year intervals are compared: 1994-1997, 1998-2001 and 2002-2005 . Choosing these periods allows for comparison of the integration process both before and after the construction of the fixed link. Analysing the period 1994-2005 also presents an opportunity to examine the effects of one of the high profile bi-national institutions, Medicon Valley Academy 1 (MVA). Established in 1997, MVA is a member-financed, non-profit, network organisation working to strengthen the integration in the Öresund Region.
MVA aims to increase knowledge-sharing, innovation and competitiveness within the biotech and medico sectors in the Öresund Region . The volume of coauthorships can be seen as an image of the extent of collaboration between researchers in the two parts of the Region. Similarly the extent of collaboration is an indication of how the integration process is proceeding.
Biotech and regional growth
Biotech firms tend to locate in regions where the presence of higher-education institutions, research facilities and other biotech firms is high (Cooke, 2004) . Especially important to biotech firms, is the state-of-the-art technology which such regions offer. Another characteristic is that large hospitals e.g. university hospitals play an important role in biotech R&D. Cooke also emphasizes the importance of a well-developed network between the firms and the research institutions. Furthermore McMillan et al. (2000) finds that private biotech firms are highly dependant on public basic research. Indeed publicly funded research plays a greater role within biotech than it does in most other sciences. This is in accordance with Liebeskind et al. (1996) , who points to three characteristics within the biotech sector, which makes social networks important. First, the biotech sector is characterized by hypercompetition. This is due to rapid technological advances and innovation being an integrate part of the competition between biotech firms. As a consequence new products run the risk of being made obsolete within a relatively short period of time. Second, there is a high degree of uncertainty within the biotech sector. It is all but impossible for a biotech firm to predict which research projects will result in products ready for the market. Chances of a biomedical product making it onto the market, is no more than 10-20 %, and it is estimated that the average cost of developing a new product is around 800 million dollars (Medicon Valley Academy, 2005) . This underlines the risks taken by firms who engage in biotech research and production. Finally, a large percentage of the top scientists within biotech are employed at universities and university hospitals. As a result of this most of the R&D within biotech is centred in regions with large universities. In a Scandinavian context one such region is The Öresund Region and another is the Stockholm/Uppsala area. In light of this, the substantial agglomeration of around 300 biotech firms in The Öresund Region could in part be ascribed to the fact that the region is home to 12 universities; a relatively large number considering the size of the region.
According to Porter (2001; such agglomerations of firms into clusters are important if sustainable regional economic growth is to be secured. Inside the cluster the exchange of insights, knowledge and technology is conducted more easily between firms. This form of exchange emerges as a result of the close proximity of firms. Exchange of insights and knowledge between firms is best conducted in an environment dominated by trust, and trust is best created by face-to-face contact. Furthermore a cluster increases a firm's incentive to innovate, due to the fact that it is located in close proximity to other often rival firms. According to Cooke (2001; 958pp) some sort of equilibrium between competition and collaboration in a region is vital to the regions competitiveness, as is a general atmosphere of trust, both among firms and in the public sector. Indeed Cooke finds that regions, where there is a tradition for collaboration among firms, are more successful than regions dominated by intense rivalry.
The regional context has thus a major influence on the development and competitiveness of industries and businesses located in the region. Interactions between agents within the region have a great importance on the possibilities for creating innovative processes. It should however be noted that Audretsch & Stephan (1996) emphasize that biotech is a multidisciplinary science that draws upon knowledge from a wide range of different sources, and it is unlikely that a cluster based firm is able to source all its inputs from within the cluster. Ties to external research institutions are thus often of great importance for firms inside the biotech sector.
A greater integration between the two parts of The Öresund Region would in all probability increase the biotech cluster's competitive advantages, and thereby help to insure economic growth in the future. The question is whether a new bi-national cluster is being developed on the basis of the two clusters in Greater Copenhagen and Scania?
Method
The analysis is carried out using SCIE. -Danish public and Swedish public agents.
-Danish private and Swedish private agents.
-Danish private and Swedish public agents.
Thereby it is possible to explore whether or not there has been a change in the importance of public and private agents from the beginning of the period to the end. Furthermore the analysis points out the agents who take an active part in the co-operation across the Öresund simply by counting the number of interactions 4 . Finally the observed development will be compared to the development in the number of co-authorships between the Öresund Region and four reference areas. Thereby it will be possible to assess whether or not the development between the Danish and Swedish parts of the Öresund Region is unusual or just part of a general tendency.
It is important to recognize that the use of data from SCIE is not unproblematic as pointed out by Matthiessen & Schwarz (1999) . We have identified an additional problem as our research shows that it is not possible to use national specific characters such as the vocals ae, ø (both Danish), ä, ö (both Swedish) and å (used in both countries) in SCIE. This can cause problems in the search process as the English spelling of city names containing these letters may vary. The impact of this circumstance is minimized by searching for all possible combinations. The search will for instance in the case of the Danish place "Risø" both contain the spelling "Riso" and the spelling "Risoe". Despite of these issues we find that the method is suitable for the current analysis.
The strength of the biotech sector in the Öresund Region
The first analysis carried out is one examining the scope of biotech research in the Öresund Region in an international perspective. The OECD countries 5 are selected as a frame of reference because of the immense amount of research which is being carried out in these countries. In 2001 the OECD countries published an estimated 82 % of all papers within science and engineering (OECD n.d.).
Even though not directly transferable to biotech, it is assumed that the figures are at the same level.
During the two periods, 1994-1997 and 1998-2001 
Co-authorships in the Öresund Region within biotech
The increase in the amount of co-authorships between authors from each part of the Öresund Region has been substantial during the investigated periods-both concerning biotech and science overall. The relative increase has been larger in biotech than within science in general when observing the increase over the three periods: 1994-1997, 1998-2001 and 2002-2005 It is important to notice that the increase in the number of biotech co-authorships stretching across the Öresund is not only a result of a growth in the total number of biotech publications. Table 1 demonstrates that the share of co-authorships within biotech was 1,24 % in the first two periods before rising considerably to 1,90 % in the final period.
Characteristics of the co-authorships
The aim of this part of the analysis is to provide a detailed account of the important biotechnological agents in the Öresund Region and their role in producing co-authorships. This will clarify if there is a shift in the importance of private and public institutions. The following section will analyse the interactions between the individual firms and institutions.
This will make it possible to single out the most important agents in the production of biotech coauthorships between the two parts of the Öresund Region.
Interactions across Öresund
Illustrations showing the linkages for each of the three periods have been produced in order to visualize the development in interactions over time ( figure 3 ). Only linkages with a minimum of five interactions have been included to ensure an overview. phasized by the fact that the institution has 300 interactions during all three periods. This is almost three times as many as the University of Copenhagen (103 interactions), which is the Danish agent with the highest number of interactions. It should also be noted that only one private Swedish firm (Wieslab) has a sufficient number of interactions to be included in figure 3 . All other private agents are Danish and it is interesting to see that the University of Lund is the co-operating partner in each instance.
The Öresund Region compared to other regions with biotech strongholds
The development in co-authorships in the Öresund Region is compared to four selected reference With regard to biotech there is also an increasing tendency in the Öresund Region to produce scientific papers with researchers from other regions. Figure 5 shows the number of biotech coauthorships in the last two periods compared to the period 1994-97. When comparing the two periods 1994-1997 and 1998-2001 importance for the biotech sector as Audretsch & Stephan (1996) demonstrate and it can therefore be assumed that the construction of the fixed link has led to an increased competitiveness for the firms of the region within this sector. There is however still room for improvement as a relatively high toll for crossing prevents the region from taking the full advantage of the possibilities offered by the fixed link.
As our study shows both the Danish and the Swedish public research institutions are responsible for the vast majority of co-authorships. This is in line with the findings of McMillan et al. (2000) and Liebeskind et al. (1996) which were discussed previously: They both find that universities and hospitals are usually responsible for a significant part of the research conducted within biotech. There So far, the firms that do engage in co-authorships are mainly Danish (table 2) . As mentioned previously this is in part due to differences in the number of firms. It is however surprising that the disparity is this significant. Part of the explanation may be that the biotech research facilities in Lund have very high standards. Especially the Biomedical Centre (BMC) in Lund is an attractive collaborating partner for Danish firms (Hansen & Hansen 2006) . The high standards of BMC could also lower the incentives for Scanian companies to co-operate with Danish institutions. After all, when firms have the demanded inputs nearby it is most often easier to use these instead of inputs localised outside of the local area. Another possible reason is that Danish biotech firms attract many Swedish employees. This is mainly due to differences in the unemployment rate (Eurostat 2006) and wages (Örestat 2006) Comparing figures 4 and 5 it is clear that the increase in co-authorships between the two parts of the Öresund Region related to biotech is in excess of 15 % above the increase in co-authorships overall.
An important reason for this is probably the efforts made by MVA. MVA has created a strong brand which in turn has increased the possibility to draw attention towards the strength and the quality of the biotech cluster in the region. This is of course important with regard to external agents, but it is also vital in strengthening the internal ties in the region. As MVA furthermore acts as a platform for interaction between agents it is reasonable to assume that the organization has played an important role in the integration process between the two parts of the Öresund Region within the biotech sector.
Conclusion
Our study has provided insight into the current integration process between the Danish and the Swedish part of the Öresund Region within the world of science, more specifically within biotech.
This sector has been examined because it is of considerable importance for the economic development of the region. Furthermore the biotech sector requires access to well-developed networks, skilled labour and the most recent scientific results as it is also illustrated by the examined literature. This means that especially this sector will benefit from a more integrated Öresund Region.
By investigating the development in the number of co-authorships from 1994 to 2005, our study has provided an indication on how the integration in the region is proceeding. A main finding is that there has been a substantial increase in both the number of all co-authorships and co-authorships within the biotech sector. In relative terms the rise is largest with regard to biotech. The increase is mainly due to intensified co-operation between Danish and Swedish public institutions, but a rising importance of the collaboration between public Swedish and private Danish agents can also be observed. The importance of private agents is still modest compared to the public agents, but it is however rising.
When looking at the individual interactions between agents it is seen that a substantial higher number of Danish agents are involved in the writing of co-authorships compared to the number of Swedish agents. There are a few Swedish institutions -most notably the University of Lund -which are heavily involved in co-operation with Danish agents, but the number of private Swedish agents who participate in such collaborations is very limited. This is in part due to the different structures of the university systems in the two parts of the region, where the Swedish system is more centralized than the Danish.
Finally, our study has also shown that the rise in the number of co-authorships within the Öresund region is significant seen from an international perspective -especially concerning the biotech sector. Compared to the four reference areas (USA, England, Germany and the Stockholm Region) it is found that the relative increase within the Öresund Region is the largest with regard to all coauthorships. The relative increase is by far larger than that of any of the reference areas when looking solely at the biotech sector. The figures also indicate that the Swedish part of the region is increasingly orientating itself towards the Danish part of the region at the expense of the Stockholm area. All in all our analysis indicates a growing functional integration within the world of science in the Öresund Region -and it is a very strong indication of an increasing functional integration within the biotech sector specifically. This suggests that the bi-national biotech cluster in the Öresund
Region is on its way to being fully developed thereby helping to ensure the economic growth in the future.
As a concluding remark it must be stressed that the results found in this study is not directly transferable to all other types of industries. Thus this analysis alone does not make it possible to describe the general progress of the integration in the Öresund Region. There may for instance be considerable differences between more and less knowledge intensive industries. A less knowledge intensive industry, e.g. logistics, is also of great importance for the economic development in the Öresund
Region and it would therefore be interesting to examine how the integration processes elapses within this sector. The attitudes and actions of everyday residents in the region are also of importance.
Bucken- Knapp (2001; 51) notes that "… in order to study whether the considerable efforts at establishing a cross border metropolitan region will be successful, it becomes necessary to benchmark the attitudes and behaviour of everyday residents in the Øresund". Our study has provided conclusions about integration succes within the biotech sector, but in a long term perspective economic growth is dependent on a broad integration, and in-depth studies of other sectors are therefore also needed.
The development in the number of co-authorships between the different areas 
